Who is sponsoring NCT04934280?

NCT04934280 is sponsored by Sohag University.

What drugs are being tested in NCT04934280?

Interventions in NCT04934280: sonohysterography.

What condition does NCT04934280 study?

NCT04934280 studies Cesarean Section Niche Evaluation.

Is NCT04934280 still recruiting?

NCT04934280 is currently status unknown. Last updated 22 June 2021.

Last reviewed 2021-06-22 · How we verify

NCT04934280

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Diagnostic Yield of Transvaginal Ultrasonography Versus Sonohysterography in Detection of Ceserean Section Niche

Status unknown NA Last updated 22 June 2021

What this trial tests

NA trial testing sonohysterography in Cesarean Section Niche Evaluation in 2 participants. Status unknown.

Timeline

20 June 2021

Primary endpoint
20 December 2021

20 February 2022

Quick facts

Lead sponsor	Sohag University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	diagnostic
Enrollment	2
Start date	20 June 2021
Primary completion	20 December 2021
Estimated completion	20 February 2022

Drugs / interventions tested

sonohysterography

Conditions studied

Cesarean Section Niche Evaluation — all drugs for Cesarean Section Niche Evaluation →

Sponsor

Sohag University

Who can join

Eligibility, female only, with Cesarean Section Niche Evaluation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to compare the identification of CS scar niche between 2D transvaginal ultrasonography alone and with the use of saline infusion as a contrast. Does it differ in the measurements and identification or not.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Diagnostic yield of transvaginal ultrasonography versus saline: infused sonohysterography in the evaluation of post-cesarean section uterine niche.
Ahmad MIM, Mohammed AH, Ali WA, Bahy RAE, et al · · 2025 · cited 1× · PMID 39556186 · DOI 10.1007/s40477-024-00969-7

Verify or expand the search:

Other Sohag University trials

Trials by the same sponsor.

NCT07119905 — Association Between Matrix Metalloproteinase-9 Gene Polymorphism and Susceptibility to Primary Open Angle Glaucoma Patie · not yet recruiting
NCT07512219 — Comparison Between Greater Occipital Nerve Block and Pulsed Radiofrequency in the Management of Chronic Migraine · NA · not yet recruiting
NCT07519694 — Comparative Study Between Different Additives to Lidocaine 2٪ for Peribulbar Block in Vitreoretinal Surgery · NA · not yet recruiting
NCT07515365 — Colitis Patterns in Patients With Lower GI Symptoms · not yet recruiting
NCT07523386 — Compartive Study Between Cannulated Screw and Kws in Fixation of Distal Radius · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04934280 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Sohag University
Last refreshed: 22 June 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04934280.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing